Collaboration Agreements in the Pharmaceuticals Industry

237 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to License and Collaboration Agreement, dated as of June 10, 2022, by and between Pfizer Inc. and Priovant, Inc
Collaboration Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Clinical Trial Collaboration Agreement
Collaboration Agreements
Dermata Therapeutics, Inc.
Pharmaceuticals
2025
First Amendment to Collaboration and License Agreement, dated as of May 14, 2024, by and between the Registrant and Torii Pharmaceuticals Co., Ltd
Collaboration Agreements
Verrica Pharmaceuticals Inc.
2024
Amendment to Research Collaboration and License Agreement with Giiant Pharma, Inc. dated August 2, 2024
Collaboration Agreements
Neuralstem, Inc.
2024
Collaboration Agreement between Rani Therapeutics, LLC and ProGen Co., Ltd. dated June 17, 2024
Collaboration Agreements
Rani Therapeutics Holdings, Inc.
2024
Amendment to Collaboration and License Agreement between Innovent Biologics (Suzhou) Co. Ltd. and AnHeart Therapeutics Inc, dated November 30, 2022
Collaboration Agreements
Panacea Acquisition Corp
2024
Collaboration and License Agreement between Innovent Biologics (Suzhou) Co. Ltd. and AnHeart Therapeutics Inc, dated May 31, 2021
Collaboration Agreements
Panacea Acquisition Corp
2024
Research Collaboration Agreement, dated as of June 7, 2023, by and between the Company and PoloMar Health
Collaboration Agreements
PaxMedica, Inc.
2024
Form of Research Collaboration and License Agreement with Giiant Pharma
Collaboration Agreements
Neuralstem, Inc.
2023
First Amendment to Collaboration and License Agreement, effective as of April 20, 2023, by and between the Registrant and MyoKardia, Inc., a wholly-owned subsidiary of Bristol...
Collaboration Agreements
Fulcrum Therapeutics, Inc.
2023
Master Collaboration Agreement, dated November 1, 2021, between MIRA Pharmaceuticals, Inc. and The Johns Hopkins University
Collaboration Agreements
MIRA PHARMACEUTICALS, INC.
2023
Collaboration and License Agreement, dated January 6, 2023, between CymaBay Therapeutics, Inc. and Kaken Pharmaceutical Co., Ltd
Collaboration Agreements
CymaBay Therapeutics, Inc.
Pharmaceuticals
NY
2023
Collaboration and Supply Agreement, dated November 16, 2022, between Marinus Pharmaceuticals, Inc. and Tenacia Biotechnology (Shanghai) Co., Ltd
Collaboration Agreements
MARINUS PHARMACEUTICALS INC
Pharmaceuticals
NY
2023
Amendment No. 3 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc (formerly Arvinas, Inc.), dated December 21, 2022
Collaboration Agreements
ARVINAS, INC.
Pharmaceuticals
2023
License and Collaboration Agreement dated as of November 21, 2022
Collaboration Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
License and Collaboration Agreement, dated October 18, 2022, between Jazz Pharmaceuticals Ireland Limited and Zymeworks BC Inc
Collaboration Agreements
Jazz Pharmaceuticals plc
Pharmaceuticals
WA
2022
First Amendment to License and Collaboration Agreement, dated September 26, 2022, between Registrant and LianBio Inflammatory Limited and LianBio
Collaboration Agreements
Lyra Therapeutics, Inc.
Pharmaceuticals
NY
2022
Clinical Trial Collaboration and Supply Agreement, dated August 1, 2022, by and between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group
Collaboration Agreements
Context Therapeutics Inc.
Pharmaceuticals
NY
2022
Third Amendment to Collaboration Agreement, dated July 13, 2022, by and among Innoviva, Inc., Glaxo Group Limited, and Theravance Respiratory Company, LLC
Collaboration Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2022
License and Collaboration Agreement, dated as of September 13, 2021, by and between Pfizer Inc. and Priovant, Inc
Collaboration Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Amended and Restated Promotion and Collaboration Agreement, effective as of January 1, 2022, by and between MC2 Therapeutics Limited and EPI Health, LLC
Collaboration Agreements
Novan, Inc.
Pharmaceuticals
NY
2022
First Amendment to Collaboration and License Agreement by and between Wave Life Sciences USA, Inc., Wave Life Sciences UK Limited and Takeda Pharmaceutical Company Limited, dated...
Collaboration Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
2022
Amendment No. 2 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc. (formerly Arvinas, Inc.), dated January 14, 2022
Collaboration Agreements
ARVINAS, INC.
Pharmaceuticals
2022
Amended and Restated Collaboration and License Agreement between Nanomerics Ltd. and Virpax Pharmaceuticals, Inc., dated as of March 9, 2022
Collaboration Agreements
Virpax Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Certain information has been excluded from this agreement (indicated by [***]) because such information is both not material and the type that the registrant treats as private or...
Collaboration Agreements
ANI Pharma Inc
Pharmaceuticals
NY
2022
Second Amendment to Collaboration and License Agreement by and between Wave Life Sciences USA, Inc., Wave Life Sciences UK Limited and Takeda Pharmaceutical Company Limited, dated...
Collaboration Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
2022
Amendment No. 2 to Strategic Collaboration Agreement dated as of January 12, 2022, by and between Bristol-M
Collaboration Agreements
NEKTAR THERAPEUTICS
Pharmaceuticals
2022
Collaboration and License Agreement, dated as of December 6, 2021, by and between Aerie Pharmaceuticals Ireland, Ltd. and Santen SA
Collaboration Agreements
AERIE PHARMACEUTICALS INC
Pharmaceuticals
NY
2022
Collaboration Agreement, dated as of July 30, 2021, by and between Marinus Pharmaceuticals, Inc. and Orion Corporation
Collaboration Agreements
MARINUS PHARMACEUTICALS INC
Pharmaceuticals
PA
2021
License, Collaboration, and Assignment Agreement for DFD-29, entered into by and between Journey Medical Corporation and Dr. Reddys Laboratories Ltd., dated as of June 29, 2021
Collaboration Agreements
Journey Medical Corp
Pharmaceuticals
NY
2021
Collaboration Agreement
Collaboration Agreements
IMAGING3 INC
Pharmaceuticals
2021
Amended and Restated License and Collaboration Agreement, by and between the Registrant and Aventis Inc., dated as of December 17, 2015, as amended and restated as of August 16,...
Collaboration Agreements
DiCE MOLECULES HOLDINGS, LLC
Pharmaceuticals
NY
2021
Amendment No. 1 to Collaboration and License Agreement, effective as of April 8, 2021, by and between the Company and Commave Therapeutics SA
Collaboration Agreements
KEMPHARM, INC
Pharmaceuticals
2021
License and Collaboration Agreement by and among the Company and Ji Xing Pharmaceuticals, Limited, dated May 15, 2021
Collaboration Agreements
Milestone Pharmaceuticals Inc.
Pharmaceuticals
NY
2021
Amendment to the Collaboration and License Agreement dated April 11, 2019, as amended, between Nanomerics Ltd. and Virpax Pharmaceuticals Inc., dated May 5, 2021
Collaboration Agreements
Virpax Pharmaceuticals, Inc.
Pharmaceuticals
2021
Amendment to the Collaboration and License Agreement dated April 11, 2019, as amended, between Nanomerics Ltd. and Virpax Pharmaceuticals, Inc., dated April 6, 2021
Collaboration Agreements
Virpax Pharmaceuticals, Inc.
Pharmaceuticals
2021
License and Collaboration Agreement dated May 31, 2021, by and between the Registrant and LianBio Inflammatory Limited and LianBio
Collaboration Agreements
Lyra Therapeutics, Inc.
Pharmaceuticals
NY
2021
Collaboration and License Agreement, effective as of June 9, 2021, by and between Verona Pharma plc, Nuance Pharma Limited and Nuance (Shanghai) Pharma Co Ltd
Collaboration Agreements
Verona Pharma plc
Pharmaceuticals
NY
2021
Exclusive Collaboration and License Agreement by and between the Company and Lian Respiratory Limited, dated May 14, 2021
Collaboration Agreements
Landos Biopharma, Inc.
Pharmaceuticals
NY
2021
Collaboration Agreement, dated July 21, 2021, by and between Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc. and Pfizer, Inc
Collaboration Agreements
ARVINAS, INC.
Pharmaceuticals
NY
2021